GI - IBD Pathology and Presentation Flashcards
Outline the pathological (macroscopic) differences between UC and Crohn’s
-Location: (UC) Rectum + colon +- backwash ileitis vs (Crohns) Mouth to anus, espcially terminal ileum
-Distribution: contiguous vs skip lesions
Strictures: no vs yes
Outline the pathological (microscopic) differences between UC and Crohn’s
- Inflammation: muscosal vs transmural
- Ulceration: shallow and broad vs deep cobblestone mucosa
- Fibrosis: none vs marked
- Granulomas: none vs present
- Pseudopolyps: marked vs minimal
- Fistulae: none vs present
Describe a UC presentation
- Systemic: fever, malaise, anorexia, wt loss (in active disease)
- Abdominal: diarrhoea. blood and mucus (PR), abdo discomfort, tenesmus and faecal urgency
- Signs Abdominal: fever, tender and distended abdo
- Signs extra abdominal: Skin (clubbing, erythema nodosum, pyoedema), Eyes (iritis, conjunctivitis, episcleritis, scleritis)
Describe UC complications
- Toxic megacolon (diameter of >6cm, risk of perforation)
- Bleeding
- Malignancy (10% for evert 10 years)
- Cholangiocarcinoma
- Strictures leading to obstruction
- Venous thrombosis
Describe a Crohn’s presentation
- Systemic: fever, malaise, anoresia, wt loss (in active disease)
- Abdominal: diarrhoea (usually not bloody), abdo pain
- Abdominal signs: abdo tendernes, RIF mass, perianal abscesses, fistulae, tags, anal and rectal strictures
- Extra abdo signs: arthritis (non deforming and asymmetrical), sacro-iliitis, gallstones/fatty liver, amyloidosis and oxalate renal stones
Complications in Crohn’s
- Fistulae: Entero-colonic (diarrhea), entero-vesical (freqeuncy/UTI), entero-vaginal, perianal
- Strictures: obstruction
- Abscesses (abdominal or anorectal)
- Malabsorption: fat (steatorrhea/gallstones), B12 (megalobastic anaemia), Vit D (osteomalacia), protein (oedema)
- Toxic megacolon and Ca can occur but < than UC
UC: prevalence:
- Most common form of IBD
- Most prev among Caucasian pop, 15-25ya and 55-65ya
UC: differentials
- Crohn’s (primary Dx)
- Chronic infections (schisto, giardia, TB)
- mesenteric ischaemia
- radiation colitis
- Malignancy
- IBS
- Coeliac disease
UC: investigations - bloods and samples
- Bloods: FBC, U&Es, CRP, LFT and clotting - examine for anaemia, low albumin, raised CRP and WCC
- Faecal calprotectin test: in patients with recent onset lower GI problems
- Stool sample: exclude campy, shigella, salmonella, c diff
UC: investigations - imaging and others
- Colonoscopy with biopsy: provides definitive Dx - characteristic findings are continuous inflammation with ulcers, visible pseudopolyps
- Can do flexi-sig
- Acute exacerbations: AXR helps determine whether there is toxic megacolon/bowel performation
- Chronic UC cases may show lead-pipe colon,
- Ba/gastrograffin enema
UC: Mx- acute severe UC
- Resus: Admin, IV, NBM
- Hydrocortisone: IV 100mg QDS + PR
- Transfuse if required
- Thromboprophylaxis: LMWH
- Monitoring: bloods (FBC, ESR, CRP, U&E), vitals + stool chart, AXR
- avoid anti-motility drugs (loperamide) in acute attacks - can precipitate toxic megacolon
- ABX do not seem to benefit - not routinely recommended, may be used if megacolon, perforation or undertain Dx
UC: Acute complications
- Performation
- Bleeding
- Toxic MC
- VTE
UC: stepwise treatment approach
- Mild-mod (proctitis): Step 1 (topical mesalazine or sulfazalaxine), step 2 (add oral pred + oral tacrolimus)
- Mild to mod (extensive inflammation): Step 1 (high oral dose mesalazine or sulfazalazine) + step 2 as above
- Severe: Step 1 (IV corticosteroids and assess the need for surgery) + Step 2 (add infliximab if no short term response)
UC: maintaining remission
- Can be maintained with immunomodulators (mesalazine/sulfasalazine)
- Pts at increased risk of colorectal malignancy t/f: colonoscopuc surveillance offered for pts with 10+ ya Hx of UC
UC: further Mx
- IBD nurse specialists/pt support groups
- Enteral nutritional support: considered in young pts with growth concerns
- ABX: only offered with obvious concurrent disease (ciprofloxacin/metronidazole)